Cargando…

Efficacy and safety of keishibukuryogan, a traditional Japanese Kampo medicine, for hot flashes in prostate cancer patients receiving androgen deprivation therapy

BACKGROUND: The efficacy and safety of keishibukuryogan, a traditional Japanese medicine, were investigated for the treatment of hot flashes in prostate cancer (PC) patients receiving androgen deprivation therapy. METHODS: Thirty patients were enrolled and orally administered 2.5 g keishibukuryogan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shigehara, Kazuyoshi, Izumi, Kouji, Nakashima, Kazufumi, Kawaguchi, Shohei, Nohara, Takahiro, Kadono, Yoshifumi, Mizokami, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807326/ https://www.ncbi.nlm.nih.gov/pubmed/33457227 http://dx.doi.org/10.21037/tau-20-901

Ejemplares similares

Efficacy of keishibukuryogan for hot flashes in prostate cancer patients receiving androgen deprivation therapy: a sub-analysis focusing on hormonal and cytokine levels
por: Shigehara, Kazuyoshi, et al.
Publicado: (2023)

Impact of Pelvic Anatomical Changes Caused by Radical Prostatectomy
por: Kadono, Yoshifumi, et al.
Publicado: (2022)

Suprapubic cystostomy during renal transplantation in a patient with a urethral stricture after hypospadias surgery: A case report
por: Kawaguchi, Shohei, et al.
Publicado: (2019)

Risk Factors Affecting Decreased Libido Among Middle-Aged to Elderly Men; Nocturnal Voiding is an Independent Risk Factor of Decreased Libido
por: Shigehara, Kazuyoshi, et al.
Publicado: (2021)

A case of adrenal lymphangioma resected laparoscopically with minimal invasiveness
por: Yaegashi, Hiroshi, et al.
Publicado: (2020)

Relation between athletic club affiliation from school age and future serum free testosterone levels in Japan: A cross‐sectional study
por: Kato, Yuki, et al.
Publicado: (2023)

Testosterone and Bone Health in Men: A Narrative Review
por: Shigehara, Kazuyoshi, et al.
Publicado: (2021)

Androgen replacement therapy for cancer‐related symptoms in male: result of prospective randomized trial (ARTFORM study)
por: Izumi, Kouji, et al.
Publicado: (2021)

Investigating the mechanism underlying urinary continence using dynamic MRI after Retzius-sparing robot-assisted radical prostatectomy
por: Kadono, Yoshifumi, et al.
Publicado: (2022)

Carbon dioxide gas embolism during robot‐assisted laparoscopic partial nephrectomy
por: Nakagawa, Ryunosuke, et al.
Publicado: (2022)

Decreased febrile neutropenia during inpatient chemotherapy for urologic cancer during coronavirus disease 2019 pandemic
por: Toriumi, Ren, et al.
Publicado: (2022)

Comparison of Clinical Outcomes between Robot-Assisted Partial Nephrectomy and Cryoablation in Elderly Patients with Renal Cancer
por: Kawaguchi, Shohei, et al.
Publicado: (2022)

A novel risk classification score for malignant ureteral obstruction: a multicenter prospective validation study
por: Izumi, Kouji, et al.
Publicado: (2021)

Human papillomavirus 16–positive penile Bowen’s disease involving the distal urethra: A case report
por: Sakamoto, Jiro, et al.
Publicado: (2020)

Three-dimensional morphological analysis of spermatogenesis in aged mouse testes
por: Nakano, Taito, et al.
Publicado: (2021)

Analysis of the Safety of Pegfilgrastim Addition in Bleomycin, Etoposide, and Cisplatin Treatment Patients With Germ Cell Tumors
por: Nakagawa, Ryunosuke, et al.
Publicado: (2022)

Does Bladder Cancer with Inchworm Sign Indicate Better Prognosis after TURBT?
por: Nakagawa, Ryunosuke, et al.
Publicado: (2022)

Contribution of Retzius-sparing robot-assisted radical prostatectomy to the mechanism of urinary continence as demonstrated by dynamic MRI
por: Kadono, Yoshifumi, et al.
Publicado: (2023)

Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review
por: Kadomoto, Suguru, et al.
Publicado: (2020)

Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese Men
por: Nakagawa, Ryunosuke, et al.
Publicado: (2022)

Japanese herbal Kampo medicine, Keishibukuryogan, for chronic subdural hematoma – Prospective observational study
por: Katsuki, Masahito, et al.
Publicado: (2022)

Ischemic proctitis after low‐dose‐rate brachytherapy using hydrogel spacer for prostate cancer
por: Toriumi, Ren, et al.
Publicado: (2022)

Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20–CCR6 axis
por: Kano, Hiroshi, et al.
Publicado: (2022)

Identification of a Predictive Biomarker for the Beneficial Effect of Keishibukuryogan, a Kampo (Japanese Traditional) Medicine, on Patients with Climacteric Syndrome
por: Namiki, Takao, et al.
Publicado: (2014)

A novel screening strategy for clinically significant prostate cancer in elderly men over 75 years of age
por: Iwamoto, Hiroaki, et al.
Publicado: (2020)

Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer
por: Iwamoto, Hiroaki, et al.
Publicado: (2022)

Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer
por: Iwamoto, Hiroaki, et al.
Publicado: (2022)

Relationship between Testosterone and Sarcopenia in Older-Adult Men: A Narrative Review
por: Shigehara, Kazuyoshi, et al.
Publicado: (2022)

Effect of Keishibukuryogan, a Japanese Traditional Kampo Prescription, on Improvement of Microcirculation and Oketsu and Induction of Endothelial Nitric Oxide: A Live Imaging Study
por: Tomita, Tsutomu, et al.
Publicado: (2017)

Prevalence of human papillomavirus infection in the oropharynx and urine among sexually active men: a comparative study of infection by papillomavirus and other organisms, including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma spp., and Ureaplasma spp
por: Nakashima, Kazufumi, et al.
Publicado: (2014)

Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL
por: Iwamoto, Hiroaki, et al.
Publicado: (2019)

Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells
por: Izumi, Kouji, et al.
Publicado: (2019)

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan
por: Kitagawa, Yasuhide, et al.
Publicado: (2014)

Tumor necrosis factor‐α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation
por: Maolake, Aerken, et al.
Publicado: (2018)

CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells
por: Natsagdorj, Ariunbold, et al.
Publicado: (2018)

Keishibukuryogan is not carcinogenic in Sprague-Dawley rats
por: Kanitani, Masanao, et al.
Publicado: (2016)

A Review on the Mechanism and Application of Keishibukuryogan
por: Tanaka, Koichiro, et al.
Publicado: (2021)

Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice
por: Mizokami, Atsushi, et al.
Publicado: (2017)

Reply to Comment on “Kadomoto, S. et al. Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis” Cancers 2020, 12, 89
por: Kadomoto, Suguru, et al.
Publicado: (2020)

Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis
por: Kadomoto, Suguru, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ajc1sgpmn1974qohgrjuip834h